Roadmap
A stage-gate path from bench to commercial scale.
Each stage has a clear objective and explicit go / no-go metrics. Capital is committed only when the prior gate is cleared, phasing protects credibility and runway.
- 0
Stage 0, Strategy lock
Choose initial product and feedstock shortlist.
Go / no-go
Written scope: oxide vs metal/alloy vs magnet; 2–3 feedstocks identified.
- 1
Stage 1, Assay & desktop TEA
Screen feedstock economics.
Go / no-go
TREO distribution, NdPr/Dy/Tb value, NORM risk, delivered cost.
- 2
Stage 2, Bench chemistry
Prove recovery and purity direction.
Go / no-go
Recovery %, D values, β, impurity reduction, reagent intensity.
- 3
Stage 3, Kinetic intensification
Test the continuous-processing thesis.
Go / no-go
Time-to-equilibrium reduction, kWh/kg, kg/hr, no purity regression.
- 4
Stage 4, Pilot
Demonstrate integrated continuous operation.
Go / no-go
Sustained recovery & purity at pilot scale, OPEX/kg envelope.
- 5
Stage 5, Demonstration & commercial
Scale to qualified commercial output.
Go / no-go
Offtake coverage, customer qualification, financeable TEA.
Development framework
How we are building the venture.
The dimensions that shape the platform, where each one stands today, and the work in progress to advance it.